CORR:OA患者关节置换术后身体活动水平并无提高

2014-05-27 佚名 丁香园

老年骨性关节将导致患者关节疼痛和功能障碍,影响患者的日常及工作活动。全髋、全膝关节置换可以迅速缓解疼痛、改善肢体功能,提高生活质量。但是关节置换术后患者的的身体活动情况在术后能否得到提高却一直没有明确的研究。【原文下载】 针对上述问题,澳大利亚的Paula Harding D医生首次使用GT1M加速器对全髋全膝关节置换患者的身体活动情况进行了一项研究,发现骨性关节炎患者进行关节置换术后患者客

老年骨性关节将导致患者关节疼痛和功能障碍,影响患者的日常及工作活动。全髋、全膝关节置换可以迅速缓解疼痛、改善肢体功能,提高生活质量。但是关节置换术后患者的的身体活动情况在术后能否得到提高却一直没有明确的研究。【原文下载】

针对上述问题,澳大利亚的Paula Harding D医生首次使用GT1M加速器对全髋全膝关节置换患者的身体活动情况进行了一项研究,发现骨性关节炎患者进行关节置换术后患者客观上的身体活动情况并未有明显改善,患者在术前和术后均喜欢久坐,其体力活动能力并没有达到美国国民体育运动健身指南中建议的标准,其结果发表在2014年5月的 Clinical Orthopaedics and Related Research杂志上。

57例老年骨性关节炎接受关节置换的患者进入研究,所有患者在关节置换术前无需乘坐轮椅可自由活动并且没有脑中风及认知障碍,其中33例患者进行全膝关节置换,24例进行全髋关节置换。有44例患者完成整个随访及检查。

患者在关节置换术后进行标准的物理治疗,包括术后1天在助行器及理疗师帮助下开始负重行走,并进行床上运动练习。使用GT1M加速器测量患者术前及术后6个月时的运动情况,并对患者疼痛、髋膝关节评分、生活质量等情况进行评估和分析。

患者在关节置换术前一天中有82%的时间是坐着不动的,一部分人自述有时参加散步、有限的购物等轻度活动。在术后6个月时,接受全髋置换或全膝关节置换的患者通过GT1M加速器客观测量到的体力运动情况和术前并未有明显改变,一天中有83%的时间患者是坐着不动的。

在关节置换术前,57例患者中只有3例患者的体力运动达到美国国民体育运动健身指南对于身体活动的要求,而在术后6个月时,资料完整的52例患者中只有1例全髋关节置换的患者能够达到健身指南要求。




虽然患者客观上的运动情况并未因关节置换手术而获得明显改变。但是绝大多数患者疼痛明显缓解、功能得到改善、生活质量显著提高。

因此作者建议医生调整治疗及康复方案以提高关节置换患者的身体活动能力改善其健康水平,需要对影响关节置换术后的身体活动水平的因素进行进一步的研究。

原始出处:

Harding P1, Holland AE, Delany C, Hinman RS.Do activity levels increase after total hip and knee arthroplasty?Clin Orthop Relat Res. 2014 May;472(5):1502-11. doi: 10.1007/s11999-013-3427-3. Epub 2013 Dec 19.【原文下载】


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754137, encodeId=3dd31e54137cf, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Wed Sep 03 21:23:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742285, encodeId=c5be1e4228547, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Thu Aug 21 01:23:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410655, encodeId=8c00141065538, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576482, encodeId=243e15e6482d1, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590676, encodeId=f38715906e6fe, content=<a href='/topic/show?id=e31d134e83e' target=_blank style='color:#2F92EE;'>#ORR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13478, encryptionId=e31d134e83e, topicName=ORR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b17846501, createdName=psybestwish, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754137, encodeId=3dd31e54137cf, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Wed Sep 03 21:23:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742285, encodeId=c5be1e4228547, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Thu Aug 21 01:23:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410655, encodeId=8c00141065538, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576482, encodeId=243e15e6482d1, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590676, encodeId=f38715906e6fe, content=<a href='/topic/show?id=e31d134e83e' target=_blank style='color:#2F92EE;'>#ORR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13478, encryptionId=e31d134e83e, topicName=ORR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b17846501, createdName=psybestwish, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]
    2014-08-21 yxch48
  3. [GetPortalCommentsPageByObjectIdResponse(id=1754137, encodeId=3dd31e54137cf, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Wed Sep 03 21:23:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742285, encodeId=c5be1e4228547, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Thu Aug 21 01:23:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410655, encodeId=8c00141065538, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576482, encodeId=243e15e6482d1, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590676, encodeId=f38715906e6fe, content=<a href='/topic/show?id=e31d134e83e' target=_blank style='color:#2F92EE;'>#ORR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13478, encryptionId=e31d134e83e, topicName=ORR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b17846501, createdName=psybestwish, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1754137, encodeId=3dd31e54137cf, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Wed Sep 03 21:23:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742285, encodeId=c5be1e4228547, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Thu Aug 21 01:23:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410655, encodeId=8c00141065538, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576482, encodeId=243e15e6482d1, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590676, encodeId=f38715906e6fe, content=<a href='/topic/show?id=e31d134e83e' target=_blank style='color:#2F92EE;'>#ORR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13478, encryptionId=e31d134e83e, topicName=ORR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b17846501, createdName=psybestwish, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1754137, encodeId=3dd31e54137cf, content=<a href='/topic/show?id=7d3330135ac' target=_blank style='color:#2F92EE;'>#关节置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30135, encryptionId=7d3330135ac, topicName=关节置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=050736663344, createdName=apoenzyme, createdTime=Wed Sep 03 21:23:00 CST 2014, time=2014-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742285, encodeId=c5be1e4228547, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Thu Aug 21 01:23:00 CST 2014, time=2014-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410655, encodeId=8c00141065538, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576482, encodeId=243e15e6482d1, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590676, encodeId=f38715906e6fe, content=<a href='/topic/show?id=e31d134e83e' target=_blank style='color:#2F92EE;'>#ORR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13478, encryptionId=e31d134e83e, topicName=ORR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7b17846501, createdName=psybestwish, createdTime=Thu May 29 00:23:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]
    2014-05-29 psybestwish

相关资讯

AAOS 2014:他汀类药物或可降低关节置换术后的血栓风险

长期以来,人们对他汀类药物的认识即为降低胆固醇药物,但最近,有研究发现,在非手术健康患者中,该类药物可减低深静脉血栓形成的发生风险。在3月11日的2014 美国骨外科学会(AAOS)年会上,研究者首次汇报了一项新研究,该研究显示,他汀类药物与常规血栓预防治疗联用可显著降低全关节置换(TJR)术后患者深静脉血栓形成(VTE)事件的发生风险,这项研究是相关领域进行的第一项研究。

JBJS:髋膝关节置换术后静脉血栓栓塞性疾病的预防

研究要点:1.选择关节置换术后预防静脉血栓栓塞的措施应该兼顾安全性和有效性,出血无疑会对临床结果产生负面影响。2.最近,美国骨科医师学会(AAOS)和美国胸科医师学会(ACCP)联合制定了关节置换术后预防静脉血栓栓塞的循证指南。3.对于常规的关节置换术后,应该选用哪种药物进行预防以及预防应该持续的时间,AAOS指南制定小组在现有文献的基础上尚无法给出明确的推荐。4.ACCP的指南制定小组推荐至